Cryo-Cell International, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.4M | $23.1M | $21.1M | $20.1M | $19.0M | $18.0M | $17.9M | $17.8M |
| Cost of Revenue | $6.7M | — | — | — | — | — | — | — |
| Gross Profit | $18.7M | — | — | — | — | — | — | — |
| Gross Margin | 73.5% | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $41.2K | $53.1K | $45.8K | $64.4K | $36.2K | $109.6K | $184.0K | $133.0K |
| SG&A Expense | $13.5M | $14.7M | $12.4M | $12.3M | $11.4M | $14.4M | $12.4M | $9.5M |
| Operating Income | $5.0M | $433.6K | $2.9M | $2.0M | $1.7M | $-1.7M | $-276.7K | $3.3M |
| Operating Margin | 19.7% | 1.9% | 13.9% | 9.8% | 9.0% | -9.5% | -1.5% | 18.8% |
| Interest Expense | $1.3M | $947.3K | $1.3M | $1.2M | $1.4M | $1.0M | $1.5M | $1.3M |
| Pretax Income | $3.6M | $-2.5M | $949.5K | $677.1K | $197.0K | $-4.4M | $-1.9M | $1.9M |
| Income Tax Expense | $1.3M | $-1.2M | $-7.2M | $123.5K | $169.6K | $1.9M | $171.9K | $-1.6M |
| Net Income | $2.3M | $-1.3M | $8.1M | $553.6K | $27.4K | $-6.3M | $-2.1M | $3.5M |
| Net Margin | 9.1% | -5.7% | 38.4% | 2.8% | 0.1% | -35.1% | -11.7% | 19.5% |
| EPS (Basic) | $0.33 | $-0.16 | $0.85 | $0.05 | $0.00 | $-0.56 | $-0.18 | $0.29 |
| EPS (Diluted) | $0.30 | $-0.16 | $0.83 | $0.05 | $0.00 | $-0.56 | $-0.18 | $0.29 |
| Shares Outstanding (Basic) | 7.1M | 8.1M | 9.5M | 10.2M | 10.9M | 11.3M | 11.8M | 11.8M |
| Shares Outstanding (Diluted) | 7.7M | 8.1M | 9.8M | 10.4M | 11.0M | 11.3M | 11.8M | 11.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |